Exclusive Interview / Janet Woodcock - Director, Center for Drug Evaluation and Research (CDER), US FDA
In an exclusive interview, Janet Woodcock, head of the Center for Drug Evaluation and Research (CDER) at the US…
Top Stories
News Roundup / German Pharma: February 2020
Some of the top recent stories from Germany, Europe's leading pharma market according to CPhI, including big new investments from Merck and Bayer, the implications of the country’s new Digital…
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
USA / USMCA Sets a New Standard for International Trade
Jonathan Kimball of the Association for Accessible Medicines (AAM) in the USA outlines why the signing of the…
LATAM / Colombian Tecnoquimicas’ USD 200 Million Manufacturing Investment
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion pharma market, announced a swathe…
Opinion / Politics & Markets: The Role of the Private Sector in Universal Health Coverage
Brendan Shaw outlines the long road still to travel to meet the UN Sustainable Development goal of ensuring basic…
Early Access / The UAE as an Initial Product Launch Platform
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the…
In Conversation
Tae-Han Kim – President & CEO, Samsung Biologics, South Korea
In an exclusive interview, Tae-Han Kim, president and CEO of Samsung Biologics, documents his strategy for expanding Samsung’s operations into biologics, and how Samsung Biologics has rapidly become one of the leading Contract Development Manufacturing Organisations (CDMO) in the market in only seven years. Dr Kim also provides his assessment of the CDMO market and the link between insufficient manufacturing…
Latest Reports
Focus on CEE
5 Women to Know in CEE Pharma
Here we highlight five of the most important women working in healthcare and the…
Romania’s Emergency Healthcare Ordinance: Papering Over…
State hospitals in Bucharest are increasingly overloaded with patients due to a…
Pharma Faces: Anna Wienner, IBSA Hungary
As general manager of the Hungarian affiliate of Swiss firm IBSA, Anna Wienner…
Alternative Models of Industry-Academia Research…
Hungary’s longstanding tradition of pharmacology is a major point of pride for…
Read more: CEE >>
Focus on China
New China Pharma Report February 2020 Out Now
This new issue of China Healthcare and Life Sciences Review (compiled in…
Chinese Biotechs Flock to IPO in Hong Kong
2019 was a bumper year for biotech companies listing on the Hong Kong Exchange…
Coronavirus Poised to Undermine China’s Healthcare Miracle
Eurasia Group's Aditya Bhattacharji examines the unfolding coronavirus outbreak,…
Key Highlights of China’s New Drug Administration Law
On 26 August 2019, the Chinese legislature, the National People’s Congress…
Read more: China >>
Focus on USA
The US Healthcare Insurance Industry Hits Back
In 2019, several drug companies testified to the US Senate Finance Committee on…
A More Measured Tone at J.P. Morgan Healthcare Conference…
David Crean summarises the mood at the recent J.P. Morgan Healthcare Conference…
Bringing Patient Experience to Regulatory Decision-Making:…
Takeda's Jessica S. Scott examines the steps already being taken to bring…
FDA Drugs Approved in 2019
In 2019, the US FDA's Center for Drug Evaluation and Research approved 42 novel…
Read more: USA >>
Focus on Belgium
Belgian Manufacturing’s Continuing Appeal for Global…
Over the past few decades, pharma multinationals have been increasingly drawn to…
MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the…
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the…
UCB’s Latest Investment in Belgian Biopharma Manufacturing
After reaching revenues of EUR 2.323 billion in the first six months of 2019,…
Top 20 Pharma Companies in Belgium Ranking
The top 20 pharma companies in Belgium ranked by sales in both the hospital and…
Read more: Belgium >>
Focus on Mexico
How do we Encourage Patients to Continue Taking their…
David Peña Castillo, president and founder of the Mexican Federation of Rare…
Mexico’s Healthcare System: Perspectives from the…
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de…
Mexico: Despite Hurdles, Pharma Market Remains Attractive
The United States Trade Representative Office has been engaging with a number of…
How the Pharma Industry in Mexico is Supporting Youth
Cristobal Thompson is the executive director at AMIIF (Asociacion Mexicana de…
Read more: Mexico >>
Focus on France
France’s Institut Pasteur Isolates Coronavirus; On Course…
Researchers at the Institut Pasteur in Paris have become the first in Europe to…
New France Pharma Report June 2019 Out Now
The latest issue of Healthcare & Life Sciences Review France follows on from…
Servier’s Olivier Laureau: Change Instigator
Not long ago, Laboratories Servier was considered a somewhat mysterious and…
Problems Pile Up at Ipsen after Further Clinical Setback
These are worrying times for iconic French mid-cap Ipsen. Trials for…
Read more: France >>
Focus on AMR
How Can Pharma Progress the Sustainable Development Goals?
Richard Saynor, Senior Vice President, Classic and Established Products at GSK…
UK Charities: The Funding Giants of Medical Research
One notable quirk of the British life sciences ecosystem is the importance of…
The EC’s concerns for the future of European health
At last week's European Health Forum Gastein (EHFG), the theme surrounded the…
China’s Role in Defeating Antimicrobial Resistance
According to the World Health Organization (WHO), antimicrobial resistance (AMR)…
Read more: AMR >>
Focus on UAE
Embracing Innovation: The UAE as an Initial Product Launch…
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’…
Dubai Aims to Go Paperless by 2021
Dubai's government has announced its ambition to go completely paper-free by the…
Gulf Healthcare Costs to Rise Drastically in 2020
Growing incidence of lifestyle-related diseases, coupled with high drug prices,…
UAE Accelerated Drug Approvals
The UAE ranks among the world's fastest for new drug approvals, ranking first…